1,321
Total Claims
$423K
Drug Cost
219
Beneficiaries
$1,931
Cost/Patient
Peer Comparison vs. 109,535 Physician Assistant providers
+169%
Cost per patient vs peers
$1,931 vs $719 avg
+293%
Brand preference vs peers
26.1% vs 6.7% avg
Brand vs Generic
74% generic
Brand: 345 claims · $373K
Generic: 976 claims · $50K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 213 | $252K |
| Rivaroxaban | 74 | $75K |
| Dronedarone Hcl | 22 | $24K |
| Evolocumab | 14 | $13K |
| Propafenone Hcl | 32 | $11K |
| Dofetilide | 88 | $9,920 |
| Ticagrelor | 12 | $5,717 |
| Metoprolol Succinate | 283 | $5,628 |
| Diltiazem Hcl | 67 | $4,178 |
| Sotalol Hcl | 61 | $2,758 |
| Flecainide Acetate | 20 | $2,209 |
| Amiodarone Hcl | 33 | $757 |
| Warfarin Sodium | 47 | $712 |
| Digoxin | 14 | $615 |
| Metoprolol Tartrate | 56 | $583 |
Prescribing Profile
23
Unique Drugs
$328K
Patient Profile
76
Avg Age
53%
Female
1.59
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About